Ensuring Equitable Access to Rare Disease Clinical Trials
Ensuring Equitable Access to Rare Disease Clinical Trials Promoting Equity in Access to Rare Disease Clinical Trials Why Equitable Access Is Essential in Rare Disease Trials Rare disease clinical trials face unique challenges in recruiting diverse and representative populations. With low prevalence, geographically dispersed patients, and significant health disparities across regions, ensuring equitable access is…
Read More “Ensuring Equitable Access to Rare Disease Clinical Trials” »